Quick Answer
Roivant Sciences Ltd. reported Common Stock Shares Outstanding of 695.94 million shares for the year ending 2025.
- Roivant Sciences Ltd. showed a decrease of -13.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Roivant Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: 222.67 million shares | Q3 2021: 684.79 million shares | Q4 2021: 692.01 million shares | Q2 2022: 701.17 million shares | Q3 2022: 704.39 million shares | Q4 2022: 726.80 million shares | Q2 2023: 767.14 million shares | Q3 2023: 800.79 million shares | Q4 2023: 804.89 million shares | Q2 2024: 739.05 million shares | Q3 2024: 733.33 million shares | Q4 2024: 719.63 million shares | Q1 2025: 695.94 million shares | Q2 2025: 682.23 million shares | Q3 2025: 689.70 million shares | Q4 2025: 709.69 million shares.
- Over the full 5 years of available data (2021 to 2025), Roivant Sciences Ltd.'s Common Stock Shares Outstanding has grown by 6.8%.
- Historical annual values: Fiscal year 2025: 695.94 million shares | Fiscal year 2024: 806.68 million shares | Fiscal year 2023: 760.14 million shares | Fiscal year 2022: 694.98 million shares | Fiscal year 2021: 651.58 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: